Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02057198 · ClinicalTrials.gov registry record · Phase 4
Impact of Oral Antibiotic Treatment on C. Difficile
A Phase 4 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 4
- Development phase
- 33
- Enrollment target
NCT02057198 is a Phase 4 study that has completed, run by Duke University. The registered enrollment target is 33 participants.
The verdict
NCT02057198, a Phase 4 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 33 participants
- Enrollment target
Study Summary
The overall aim is to characterize and to compare the extent and quantity of C. difficile stool shedding, perianal colonization and environmental contamination in patients who received oral fidaxomicin, oral metronidazole, or oral vancomycin. This is a prospective, randomized, microbiologic and molecular, study of environmental contamination from patients with proven C. difficile associated diarrhea (CDAD).
Interventions
- DRUG Vancomycin
- DRUG Metronidazole
- DRUG Fidaxomicin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2014-06-10 |
| Est. Completion | 2017-06-27 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02057198
The ClinicalTrials.gov registry entry for NCT02057198 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Vancomycin is the first listed.
NCT02057198 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02057198 about?
NCT02057198 is a clinical study titled "Impact of Oral Antibiotic Treatment on C. Difficile". The overall aim is to characterize and to compare the extent and quantity of C. difficile stool shedding, perianal colonization and environmental contamination in patients who received oral fidaxomicin, oral metronidazole, or oral vancomycin. This is a prospective, randomized, microbiologic and mole...
What is the current status of trial NCT02057198?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 33 participants. The study started on 2014-06-10. Estimated completion is 2017-06-27.
What interventions are being tested in trial NCT02057198?
The interventions under investigation include: Vancomycin (DRUG), Metronidazole (DRUG), Fidaxomicin (DRUG).
Who is sponsoring clinical trial NCT02057198?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.